
The Top 10 Clinical Lab Acquisitions of 2023
Seven months into the year, there were already four reported deals valued at over $1 billion in 2023, as many as in all of 2022.
Seven months into the year, there were already four reported deals valued at over $1 billion in 2023, as many as in all of 2022.
Proposed rule would require businesses to undergo even more stringent review to secure regulatory approval for such deals.
Diagnostics companies that invested heavily in COVID-19 products are relying on M&A transactions to restructure and transition.
After an eventful month in the Illumina-GRAIL saga, the story may soon be over.
G2 Intelligence’s June 13-14 virtual event offers expert advice to help labs navigate today’s economic challenges.